INS and hypertriglyceridemia: Deletion of theFOXO-1 binding site in mouse hepatocytes annuls the inhibitory action of insulin on hepatic expression ofAPOC3, and animals that constitutively express activeFOXO-1 have hypertriglyceridemia [38].